Project Grant R43AG087785
Award Date
9/25/24
Completion Date
8/31/25
Dollars Obligated
$713K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55414, USA
Similar Awards
The National Institute on Aging (NIA) awarded Rush River Research Corp a $375,704 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop and evaluate an innovative, low-cost chair designed to reduce the prevalence of pressure injuries among individuals living with Alzheimer's disease and related dementias (ADRD). The proposed chair aims to provide the functionality of an alternating pressure air surface mattress without the need for electricity or compressed air,...
The National Institute on Aging (NIA) awarded a $2,501,096 Project Grant (CFDA 93.866 - Aging Research) to the Regents of the University of Minnesota's Office of Sponsored Projects Administration on August 15, 2024. This grant, titled "Establishing Mechanisms of Benefit to Reinforce the Alzheimer's Care Experience AD/ADRD Roybal Center: EMBRACE", aims to provide scientific infrastructure to support the testing of mechanisms in tailored home and community dementia care intervention...
The National Institute on Aging (NIA) awarded a $490,262 Project Grant (CFDA 93.866 - Aging Research) to Plans4Care Inc. on June 15, 2025 to develop and test a digital platform called "Activities4Care". The platform aims to provide customized, evidence-based activity plans for caregivers of people living with Alzheimer's disease and related dementias. The key products to be delivered under this Fast-Track SBIR award include: A clickable prototype of the Activities4Care platform that...
The National Institute on Aging (NIA) awarded a $295,923 Project Grant (CFDA 93.866 - Aging Research) to Larix Bioscience LLC to develop novel hormonal therapeutics and study their efficacy with adult stem cells for the treatment of chronic pressure ulcers. The project aims to generate stable, bioactive hormone fusion biologics and evaluate their ability to enhance tissue regeneration in pressure ulcer patients, both alone and in combination with adipose-derived or induced pluripotent stem...
The National Institute on Aging (NIA) awarded a $1,010,368 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Koronis Biomedical Technologies Corp. (KBT) to develop and validate an interactive gaming platform to facilitate cognitive interventions for individuals living with mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (AD/ADRD). The goal is to create an in-home cognition training system that provides evidence-based cognitive activities...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a 5-year study to address the issue of potentially inappropriate medication (PIM) use among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The key objectives are to: 1) Identify factors and barriers/facilitators associated with routine PIM deprescribing practices for ADRD patients in home health care, using a mixed methods approach; and...
The National Institute on Aging (NIA), under the Federal Aging Research program (CFDA 93.866), awarded a $245,148 project grant to Eyenexo LLC to develop an automated rodent behavior testing system for non-invasively assessing early-stage Alzheimer's disease (AD). The project aims to develop a behavior biomarker that can differentiate AD from normal aging by studying defensive behaviors triggered by looming stimuli, which are linked to early AD pathology in the midbrain region. The 2-year...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) is providing $2,331,210 to the University of Maryland, Baltimore to develop novel analytical methods to better understand and predict post-fracture recovery trajectories in older adults living with Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered include: Novel machine learning-assisted methods to identify unique patient characteristics...
This $500,000 Project Grant was awarded on September 15, 2024 by the National Institute on Aging (CFDA 93.866 Aging Research program) to Neucyte Inc., a minority-owned small business specializing in advanced biomedical research and development. The funding will support the development of a miniaturized "mini-brain" microphysiological system (MPS) platform using Alzheimer's disease (AD) patient-derived cells. The goal is to create a scalable, reproducible in vitro brain model that can...